Cost-effectiveness of cranberry capsules to prevent urinary tract infection in long-term care facilities: Economic evaluation with a randomized controlled trial

Journal of the American Geriatrics Society

Volumn 62, Issue 1, 2014, Pages 111-116

  Van Den Hout, Wilbert B ^a   Caljouw, Monique A A ^a   Putter, Hein ^a   Cools, Herman J M ^a   Gussekloo, Jacobijn ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cranberry; economic evaluation; geriatrics; long term care facility; prevention; urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; CRANBERRY EXTRACT; PLACEBO;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE FACILITY; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; LONG TERM CARE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MICROCAPSULE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; URINARY TRACT INFECTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAPSULES; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; LONG-TERM CARE; MALE; NETHERLANDS; PHYTOTHERAPY; PLACEBOS; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON;

EID: 84892719772     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12595     Document Type: Article

References (21)

1. Nicolle LE,. Urinary tract infections in the elderly. Clin Geriatr Med 2009; 25: 423-436.
2. Foxman B,. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med 2002; 113 (Suppl 1A): 5S-13S.
3. Ruben FL, Dearwater SR, Norden CW, et al. Clinical infections in the noninstitutionalized geriatric age group: Methods utilized and incidence of infections. The Pittsburgh Good Health Study. Am J Epidemiol 1995; 141: 145-157.
4. Dwyer LL, Harris-Kojetin LD, Valverde RH, et al. Infections in long-term care populations in the United States. J Am Geriatr Soc 2013; 61: 341-349.
5. Caljouw MA, van den Hout WB, Putter H, et al. Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons. A double-blind randomized placebo-controlled trial in long-term care facilities. J Am Geriatr Soc 2014; 103-110.
6. Dolan P,. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108.
7. Lamers LM, McDonnell J, Stalmeier PF, et al. The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006; 15: 1121-1132.
8. Stiggelbout AM, Eijkemans MJ, Kiebert GM, et al. The 'utility' of the Visual Analog Scale in medical decision making and technology assessment. Is it an alternative to the time trade-off? Int J Technol Assess Health Care 1996; 12: 291-298.
9. Hakkaart-van Rooijen L, Tan SS, Bouwmans CAM,. Manual for Cost Analysis, Methods and Standard Prices for Economic Evaluations in Health Care [Dutch]. Amstelveen: Dutch Health Insurance Executive Board, 2010.
10. Wehrens R, Putter HB, Buydens LMC,. The bootstrap: A tutorial. Chemom Intell Lab Syst 2000; 54: 35-52.
11. Dijkstra A, Tiesinga LJ, Plantinga L, et al. Diagnostic accuracy of the care dependency scale. J Adv Nurs 2005; 50: 410-416.
12. Statistics Netherlands. Consumer Price Index [on-line]. Available at www.cbs.nl Accessed March 15, 2013.
13. van den Hout WB,. The GAME estimate of reduced life expectancy. Med Decis Making 2004; 24: 80-88.
14. Zethraeus N, Johannesson M, Jonsson B, et al. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003; 21: 39-48.
15. Gotteland M, Brunser O, Cruchet S,. Systematic review: Are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther 2006; 23: 1077-1086.
16. Stothers L,. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002; 9: 1558-1562.
17. Pickard AS, Johnson JA, Feeny DH, et al. Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke 2004; 5: 607-612.
18. Oostenbrink JB, Koopmanschap MA, Rutten FF,. Standardisation of costs: The Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002; 20: 443-454.
19. Conroy S, Van Der Cammen T, Schols J, et al. Medical services for older people in nursing homes-comparing services in England and the Netherlands. J Nutr Health Aging 2009; 13: 559-563.
20. Ribbe MW, Ljunggren G, Steel K, et al. Nursing homes in 10 nations: A comparison between countries and settings. Age Ageing 1997; 26 (Suppl 2): 3-12.
21. Verenso [on-line]. Available at http://www.verenso.nl/english/elderly- care-medicine/ Accessed June 15, 2012.